IL6 and Sepsis: In a mouse model of sepsis, this substance inhibited the production of TNF-α and IL-6 in peritoneal macrophages in a dose-dependent manner by inhibiting the expression of Toll-like receptor 2 (TLR2) and suppressing the activation of NF-κB [39].